Milan, 09 May 2025
PHSE, a leading global group in temperature-controlled and time critical pharmaceutical logistics, announces that today it has completed the acquisition of 100% of Sat Cargo Srl, a company specialized in international (import and export) temperature-controlled transport of pharmaceuticals, animal healths products and food supplements, with storage and “cross docking” activities at its temperature-controlled warehouse in Lainate (MI), operating at +2/+8 °C and +15/+25 °C and covering approximately 5,000 sqm.
This transaction represents a strategic step for PHSE in strengthening its position in the “Pharma and Healthcare” global forwarding segment, one of the Group’s main development directions, alongside the growth in the radiopharmaceutical sector.
Sat Cargo’s deep expertise in international transport, carried out mainly by air and sea, fits perfectly with PHSE’s operations and will benefit from the strength of the Group’s international network, currently present in 9 countries.
PHSE expects to reach consolidated revenues of €120–130 million in 2025, further strengthening its leadership in the sector

HSE is attending LogiPharma 2025, the world’s leading life sciences supply chain event.
This year’s edition celebrates 25 years as the voice of the  industry, bringing together key leaders from the pharmaceutical and MedTech supply chains to address current challenges and embrace new opportunities.

We are at booth 63, where our team meets with clients, partners, and industry professionals to share our expertise and innovative solutions in temperature-controlled pharmaceutical logistics.
At LogiPharma 2025, we explore the future of the pharma supply chain together.

We are proud to announce that PHSE is now an official member of Pharma.Aero, the
global collaborative platform revolutionizing pharmaceutical logistics. This strategic step
further strengthens our commitment to excellence in the transportation of life-saving
medicines, biotech products, and clinical supplies.

Pharma.Aero brings together key stakeholders across the supply chain to foster
innovation, enhance operational efficiency, and uphold the highest standards of quality
and safety. By joining this international network, PHSE reinforces its position as a trusted
partner in temperature-controlled pharmaceutical logistics.

With a continuous focus on improvement, we believe that collaboration with industry
leaders is essential to ensuring that critical healthcare products reach patients around the
world safely and efficiently.

This partnership marks a significant milestone in our growth journey and in our mission to
advance global health through cutting-edge logistics solutions.

We are excited to announce our participation in the 26th Clinical Trial Supply Europe 2025, one of the most important events in clinical supply chain management. This gathering brings together pharma and biotech experts to address key industry challenges and explore the latest innovations in clinical trial logistics.

This will be a unique opportunity to discover cutting-edge solutions in clinical trial logistics, build strategic connections for long-term success, and engage in discussions with industry leaders.

PHSE is proud to bring its expertise as a leader in clinical trial logistics, providing reliable and compliant solutions for the transportation of investigational drugs and sensitive materials.

With a strong commitment to innovation and quality, PHSE continues to collaborate with key industry players to tackle clinical logistics challenges and contribute to the success of pharmaceutical research worldwide.

PHSE is proud to have participated in this significant conference, an excellent opportunity to discuss the challenges and opportunities shaping the future of pharmaceutical logistics.

During the event, Paolo Gagliardi La Gala addressed fundamental topics related to sustainability, innovation, and efficiency, focusing on:

• Sustainable vehicle fleets aimed at reducing environmental impact
• Certified CO₂ calculation in compliance with ISO 14064 and 14084 standards.
• Optimization of the transport network across Italy and Europe.

However, sustainability is not only about the environment—it also involves governance and social responsibility. That is why PHSE is committed to;

• Gender equality, as certified by UNI PDR 122/2025.
• Collaboration with ESG suppliers, ensuring a responsible and transparent supply chain.

Sustainability is no longer just a duty but an opportunity for growth and innovation for the entire sector.

A heartfelt thank you to the organizers and all participants for the valuable discussions and insights!

Milan, 29 January 2025 – PHSE, a leading global group in temperature-controlled and time critical pharmaceutical logistics, announces today that it has completed the acquisition of a 70% stake in World Infinity Services SRL (WIS), a specialist Belgian logistics company focused on the international shipment of radiopharmaceuticals, the new frontier in cancer therapies.

This transaction further strengthens the PHSE Group’s focus on nuclear medicine, meeting the growing demand from pharmaceutical companies worldwide for consistent, highly specialized services capable of guaranteeing the safe international delivery of products with a very short shelf-life (even within 24/48 hours) to the patient. The acquisition also firmly establishes the Group in a new and very strategic production and distribution market, Belgium, and further expands PHSE’s overall European and Global footprint.

“We are excited to welcome World Infinity Services to our Group. WIS’s capabilities and expertise in radiopharmaceuticals, including an MIA (Manufacturer Importer Authorization) licensed facility in Liege, further enhances our GDP-compliant and IATA-certified global network for specialist healthcare distribution by air and land. Having started operations in the radiopharmaceutical market specialist segment over a decade ago, we continue to invest in our global capability in order to meet the growing needs of our customers.”, said Eddy De Vita, Executive Chairman of PHSE Group.

“We are very pleased to join a global market leader in this sector and are excited by the plans the PHSE Group has to further enhance its worldwide capabilities”, said Hans van de Maele and Andrea Demeulenaere, who will continue to run WIS, reporting to Fabio Mioli, CEO PHSE International.

As well as a global network of validated partners, the PHSE Group has 35 of its own facilities globally, employing more than 700 people and operating its own fleet of around 600 specialist vehicles. Pro-forma revenues in 2024, considering the acquisitions concluded, amounted to approximately Eu 100m.

With the desire to bring a smile and create moments of joy, PHSE is proud to have joined the solidarity initiative “A Caress for Christmas.” During the holiday season, we delivered gift packages to 500 children in over 20 hospitals across Italy, sharing happiness with those who need it most.